![](/content/dam/prnewswire/org-profiles-logos/BiolexisTherapeutics-logo-blue+(4)400.png)
Biolexis Therapeutics is a privately held clinical-stage biopharmaceutical company dedicated to developing small molecules targeting cancers, metabolic, neurodegenerative, auto-immune, and inflammatory diseases. Biolexis rapidly discovers and develops novel clinical candidates with unprecedented speed and accuracy through their proprietary MolecuLern AI-enabled drug discovery process.
- Contact Information
-
Kyle Medley
[email protected]
Latest
Journalists and Bloggers
The news you need, when you need it.
![](/content/dam/prnewswire/common/JournalistsBloggers.jpg)
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.
LEARN MORE